Placebo Effects May Explain Much of CBD's Reported Benefits for Stress
In a three-arm RCT comparing low-dose CBD oil, placebo oil, and no treatment, placebo effects accounted for a significant portion of the improvements attributed to CBD.
Quick Facts
What This Study Found
Both CBD and placebo oil groups showed improvements over the no-treatment control, suggesting that expectation and the ritual of taking a substance contribute significantly to perceived CBD benefits for stress.
Key Numbers
30-day trial with three groups: CBD oil (10% full-spectrum), placebo oil, and no-treatment control. Registered as DRKS00030971.
How They Did This
Three-arm randomized controlled trial comparing 30 days of daily sublingual low-dose (10%) full-spectrum CBD oil vs. placebo oil vs. no-treatment control in stressed university students.
Why This Research Matters
CBD products are widely marketed for stress relief, but this study suggests the act of taking something — rather than CBD itself — may drive much of the benefit. This has major implications for consumer expectations and regulatory claims.
The Bigger Picture
The CBD market is worth billions, largely built on reported benefits that may be substantially driven by placebo effects. Rigorous trials like this help separate pharmacological reality from expectation-driven outcomes.
What This Study Doesn't Tell Us
Low dose may have been insufficient for pharmacological effect. Student sample limits generalizability. 30-day duration may not capture longer-term effects.
Questions This Raises
- ?Would higher CBD doses show clearer separation from placebo?
- ?How much of the commercial CBD market's perceived value is driven by placebo and expectation effects?
Trust & Context
- Key Stat:
- Evidence Grade:
- Well-designed RCT with both placebo and no-treatment controls — strong methodology, though limited by low dose and specific population.
- Study Age:
- Recent RCT addressing a critical gap in CBD research by including a no-treatment control alongside placebo.
- Original Title:
- Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression.
- Published In:
- Journal of cannabis research, 7(1), 98 (2025)
- Authors:
- Winkler, Alexander, Meis, Annelie C, Hermann, Christiane
- Database ID:
- RTHC-07958
Evidence Hierarchy
Frequently Asked Questions
Does this mean CBD doesn't work for stress?
Not necessarily — it means that at this low dose, much of the improvement was also seen with placebo. Higher doses or different formulations might show clearer pharmacological effects.
Why is a no-treatment group important?
Without it, you can't distinguish between improvement from the substance and improvement from simply believing you're being treated. The no-treatment group shows how much natural recovery occurs without any intervention.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07958APA
Winkler, Alexander; Meis, Annelie C; Hermann, Christiane. (2025). Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression.. Journal of cannabis research, 7(1), 98. https://doi.org/10.1186/s42238-025-00366-9
MLA
Winkler, Alexander, et al. "Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression.." Journal of cannabis research, 2025. https://doi.org/10.1186/s42238-025-00366-9
RethinkTHC
RethinkTHC Research Database. "Placebo effects in a RCT assessing 30 days of low dose Canna..." RTHC-07958. Retrieved from https://rethinkthc.com/research/winkler-2025-placebo-effects-in-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.